A Phase I, Double Blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
A Phase I, Double blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to
evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Orally
Administered 'CG-745' Capsule in Healthy Male Volunteers